Hibberd, Ralph (2017) Brexit and the falsified medicines directive. Delivering Digital Drugs (17 Feb 2017). Website.
|
PDF
Download (43kB) | Preview |
Abstract
In order to help patients avoid being exposed to falsified medicines, the European Commission developed a series of measures to support patients in identifying licenced suppliers of pharmaceutical medicines, and suppliers to identify whether an end-user pack of medicines was genuine. The measures outlined in the Falsified Medicines Directive (2011/62/EU) have been applied across the European Union (EU), with the exception of requirements to verify the identity of the end-user pack, which was not due to be completed until 2019.
| Item Type: | Online resource (Website) |
|---|---|
| Official URL: | http://blogs.lse.ac.uk/ddd3/ |
| Additional Information: | © 2017 The Author(s) |
| Divisions: | Management |
| Subjects: | J Political Science > JN Political institutions (Europe) J Political Science > JN Political institutions (Europe) > JN101 Great Britain R Medicine > RM Therapeutics. Pharmacology R Medicine > RS Pharmacy and materia medica |
| Date Deposited: | 01 Jun 2017 10:33 |
| Last Modified: | 14 Sep 2024 01:22 |
| URI: | http://eprints.lse.ac.uk/id/eprint/79510 |
Actions (login required)
 |
View Item |
Download Statistics
Download Statistics